StockWatch
·

Capillary Technologies India Ltd Q2 FY27 Results

CAPILLARYQ2 FY27 Results
Filing
Result:Good· Market: Flat#Margin expansion#Base effect#Turnaround
MetricValue (₹ Cr)vs Q1 FY27
Revenue271.365.7%
Total Income277.415.7%
Expenditure257.478.4%
PBT19.94332.2%
Net Profit21.92329.4%
OPM14.55%11.86pp
NPM7.90%11.54pp
EPS2.75129.2%
View full financials

Consolidated revenue grew a strong 51% YoY to a 4-quarter high with EBITDA margin up YoY to 16.8%, but the PAT turnaround is off a near-zero base and partly reflects the prior quarter's one-off charge not repeating rather than fresh operating strength, capping it below very_good.

Q2 FY-2027 RESULTS · CAPILLARY

Capillary Q2 FY27: Consolidated PAT ₹21.9 Cr as Revenue Grows 51% YoY

PAT +7509.72% YoY · revenue +51.32% · margins expanding

02 Nov 2026 · 3 min read
Revenue

₹271.36 Cr

+51.32% YoY

PAT (consolidated)

₹21.92 Cr

+7509.72% YoY

Net margin

7.9%

EPS

₹2.75

On a consolidated basis — the primary read for Capillary, since standalone excludes its international SaaS subsidiaries — Q2 FY27 revenue from operations rose 51.3% YoY to ₹271.4 Cr (₹179.3 Cr a year ago) and 5.7% QoQ (₹256.6 Cr in Q1 FY27). Consolidated PAT was ₹21.9 Cr, against a ₹9.6 Cr loss in Q1 FY27 and a near-breakeven ₹0.29 Cr a year ago. The YoY PAT comparison is off a near-zero base, so the raw percentage change (over 7,000%) isn't a meaningful number on its own; the useful read is that consolidated net margin moved to a solid 7.9% this quarter from effectively nil a year ago and from -3.6% last quarter.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹271.36 Cr+5.7%—
Expenses₹231.88 Cr-2.4%—
PAT₹21.92 Cr+329.41%+7509.72%
Net margin7.9%+11.5pp—
EPS₹2.75+129.2%—

No year-ago quarter on record — YoY cells may be blank.

The swing from last quarter's loss is largely the reversal of a one-off: Q1 FY27 carried a ₹33.4 Cr exceptional charge tied to a cyber-enabled banking fraud at the company's Czech subsidiary, which Q2 FY27 does not repeat. Stripping that out, Q1 FY27's underlying PAT was closer to ₹23-24 Cr, so the sequential improvement in operating profitability is modest, not dramatic. EBITDA (profit before finance costs, depreciation, amortisation and tax) was ₹45.5 Cr, a 16.8% margin on revenue — up from 11.6% a year ago but down from 17.9% in Q1 FY27, as consolidated D&A rose to ₹24.5 Cr (vs ₹11.2 Cr standalone) on purchase-price-allocation amortisation from the SessionM and Kognitiv Solutions acquisitions. That same subsidiary amortisation is why standalone PAT (₹29.4 Cr) came in above consolidated PAT (₹21.9 Cr) this quarter — a divergence investors should read off the consolidated number.

₹
428.11477.68527.25576.82626.39512.7507-3008-2109-1510-0811-02Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹512.75, down 8.5% over the past month of trading.

₹ Cr
-15.95.9727.8449.717.99Q3 FY26rev ₹184 Cr43.36Q4 FY26rev ₹191 Cr-9.55Q1 FY27rev ₹257 Cr21.92Q2 FY27rev ₹271 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 4 quarters; revenue is at a 4-quarter high.

Beyond the headline

What the summary numbers don't show

EPS: consolidated basic ₹2.75 (vs ₹0.04 YoY, ₹(1.20) QoQ) — standalone basic ₹3.70

What management guided (1 FY-2027 call)
FY27 revenue target ₹1,065 Cr (vs prior ₹1,000-1,050 Cr guidance); EBITDA ₹172 Cr; management states will beat but not revising formal guidance. Organic growth expected 17-23% full year; aiRA targeting 5-10% of revenue.

— This quarter: met

Against management's own guidance (FY27 revenue of ₹1,065 Cr and EBITDA of ₹172 Cr, reiterated at the Q1 FY27 call with management saying it expects to beat without formally revising), H1 FY27 consolidated revenue of ₹539.8 Cr is already 50.7% of the full-year target and H1 EBITDA of ₹91.5 Cr is 53.2% of the EBITDA target — both tracking on pace. We found no Q2-FY27-specific Street estimates (results were filed same-day as this review); FY27 consensus tracked by Trendlyne/sharpely runs around ₹1,050 Cr revenue, broadly in line with guidance. The 17-23% organic growth management guided for FY27 can't be isolated from this filing's 51.3% reported YoY growth, which includes a full quarter of SessionM/Kognitiv contribution versus a partial one a year ago. Separately, the Board used this meeting to replace Protiviti with Deloitte Touche Tohmatsu India LLP as internal auditor effective November 2, 2026, citing the growing scale of overseas operations, finalised SessionM/Kognitiv purchase price allocation during the quarter, and named Bill Swift President-Americas in late October.

  • W1

    Insurance recovery on the ₹33.4 Cr Czech subsidiary cyber-fraud loss — investigation and claim pending as of Nov 2, 2026, nothing recovered yet

  • W2

    FY27 guidance of ₹1,065 Cr revenue / ₹172 Cr EBITDA — H1 run-rate at ~51-53% of target; H2 pace needed to confirm management's 'will beat' claim from the Q1 call

  • W3

    EBITDA margin trajectory — consolidated margin eased to 16.8% in Q2 from 17.9% in Q1 on acquisition D&A; watch whether SessionM/Kognitiv integration costs stabilise

Informational and educational content only. Not investment advice.